OR WAIT null SECS
May 28, 2019
The agency says Novartis drug is the first PI3K inhibitor to be approved for treating breast cancer.
May 24, 2019
The agency has approved Zolgensma (onasemnogene abeparvovec-xioi), the first gene therapy to treat pediatric spinal muscular atrophy.
May 23, 2019
The companies will develop a new generation of biotherapeutics from cell-line development through to GMP manufacturing.
May 20, 2019
AbbVie grants Boehringer Ingelheim a non-exclusive license to its intellectual property for Humira (adalimumab) in the United States.
May 16, 2019
The acquisition of GlaxoSmithKline’s manufacturing site in Cork, Ireland, will expand Thermo Fisher Scientific’s global footprint for complex API manufacturing.
Locate Bio has been granted additional investment to the tune of £2 million (US$2.6 million) for the expansion of its cell and gene therapy pipeline.
May 15, 2019
The acquisition provides Valby, Denmark-based Lundbeck with a discovery platform and a US-based research hub.
May 14, 2019
The new 40,000-ft2 facility will support Bayer's growing biologics portfolio in oncology, cardiology, and additional therapeutic areas.
May 13, 2019
The acquisition will expand Pfizer’s rare disease portfolio with an early pipeline candidate for treating dwarfism.
May 10, 2019
A UK-based company, Atelerix, has revealed that it has closed a second round of funding worth £700,000 (US$911,000).